Chongqing Taiji Industry Group Co Ltd Asset Resilience Ratio
Chongqing Taiji Industry Group Co Ltd asset resilience ratio. Chongqing Taiji Industry Group Co Ltd (600129) has an Asset Resilience Ratio of 0.47% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Chongqing Taiji Industry Group Co Ltd to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Chongqing Taiji Industry Group Co Ltd (1994–2025)
Asset resilience ratio of Chongqing Taiji Industry Group Co Ltd from 1994 to 2025. This chart shows how Chongqing Taiji Industry Group Co Ltd's Asset Resilience Ratio has changed over time. Read 600129 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Chongqing Taiji Industry Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Chongqing Taiji Industry Group Co Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥68.46 Million | 0.47% |
| Total Liquid Assets | CN¥68.46 Million | 0.47% |
Asset Resilience Insights
- Limited Liquidity: Chongqing Taiji Industry Group Co Ltd maintains only 0.47% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Chongqing Taiji Industry Group Co Ltd Industry Peers by Asset Resilience Ratio
Compare Chongqing Taiji Industry Group Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Ajanta Pharma Limited
NSE:AJANTPHARM |
Drug Manufacturers - Specialty & Generic | 14.99% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Porton Fine Chemicals Ltd
SHE:300363 |
Drug Manufacturers - Specialty & Generic | 6.85% |
|
Jubilant Pharmova Limited
NSE:JUBLPHARMA |
Drug Manufacturers - Specialty & Generic | 1.26% |
Chongqing Taiji Industry Group Co Ltd Asset Resilience Ratio by Year (1994–2025)
Chongqing Taiji Industry Group Co Ltd asset resilience ratio by year from 1994 to 2025. The table below shows the annual Asset Resilience Ratio data for Chongqing Taiji Industry Group Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.47% | CN¥68.46 Million ≈ $10.02 Million |
CN¥14.42 Billion ≈ $2.11 Billion |
-0.53pp |
| 2024-12-31 | 1.01% | CN¥141.49 Million ≈ $20.70 Million |
CN¥14.06 Billion ≈ $2.06 Billion |
-0.14pp |
| 2023-12-31 | 1.15% | CN¥165.87 Million ≈ $24.27 Million |
CN¥14.41 Billion ≈ $2.11 Billion |
-0.58pp |
| 2022-12-31 | 1.74% | CN¥255.24 Million ≈ $37.35 Million |
CN¥14.71 Billion ≈ $2.15 Billion |
-1.37pp |
| 2021-12-31 | 3.10% | CN¥408.87 Million ≈ $59.83 Million |
CN¥13.17 Billion ≈ $1.93 Billion |
+1.04pp |
| 2020-12-31 | 2.06% | CN¥298.60 Million ≈ $43.69 Million |
CN¥14.49 Billion ≈ $2.12 Billion |
-1.77pp |
| 2019-12-31 | 3.83% | CN¥543.39 Million ≈ $79.51 Million |
CN¥14.19 Billion ≈ $2.08 Billion |
+1.50pp |
| 2018-12-31 | 2.33% | CN¥300.00 Million ≈ $43.90 Million |
CN¥12.89 Billion ≈ $1.89 Billion |
+2.17pp |
| 2014-12-31 | 0.16% | CN¥16.53 Million ≈ $2.42 Million |
CN¥10.35 Billion ≈ $1.51 Billion |
+0.16pp |
| 2006-12-31 | 0.00% | CN¥200.00K ≈ $29.27K |
CN¥5.78 Billion ≈ $845.06 Million |
-0.05pp |
| 2003-12-31 | 0.05% | CN¥1.99 Million ≈ $290.78K |
CN¥3.94 Billion ≈ $577.15 Million |
0.00pp |
| 2002-12-31 | 0.06% | CN¥1.76 Million ≈ $257.30K |
CN¥3.20 Billion ≈ $467.62 Million |
+0.05pp |
| 2001-12-31 | 0.00% | CN¥5.00K ≈ $731.66 |
CN¥2.73 Billion ≈ $399.81 Million |
-0.12pp |
| 1998-12-31 | 0.12% | CN¥2.00 Million ≈ $292.66K |
CN¥1.61 Billion ≈ $235.04 Million |
+0.12pp |
| 1996-12-31 | 0.00% | CN¥1.70K ≈ $248.76 |
CN¥560.77 Million ≈ $82.06 Million |
-0.01pp |
| 1995-12-31 | 0.01% | CN¥20.94K ≈ $3.06K |
CN¥280.22 Million ≈ $41.01 Million |
-0.01pp |
| 1994-12-31 | 0.02% | CN¥21.87K ≈ $3.20K |
CN¥132.54 Million ≈ $19.39 Million |
-- |
About Chongqing Taiji Industry Group Co Ltd
Chongqing Taiji Industry(Group) Co.,Ltd, together with its subsidiaries, engages in the production and sales of Chinese and western medicine products in China and internationally. It operates through Pharmaceutical Industry; Pharmaceutical Business; Chinese medicinal materials Resources; Big Health and International; and Service Industry and Others segments. The company offers respiratory system,… Read more